[The abandonment of the development of flibanserin].
jeanyves.nau@gmail.com
Jean-Yves
JY
Nau
D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006801:Humans; D012702:Serotonin Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D020018:Sexual Dysfunctions, Psychological / Q000188:drug therapy
D001562:Benzimidazoles; D012702:Serotonin Antagonists; C098107:flibanserin